• DOI:10.1111/j.1365-2303.2008.00623.x
Corpus ID: 16462929

European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1

@article{Jordan2008EuropeanGF,
  title={European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1},
  author={J. Jordan and M. Arbyn and P. Martin-Hirsch and U. Schenck and J. Baldauf and D. da Silva and A. Anttila and P. Nieminen and W. Prendiville},
  journal={Cytopathology},
  year={2008},
  volume={19}
}

J. Jordan, M. Arbyn, +6 authors W. Prendiville

Published 2008

Medicine

Cytopathology

The current paper presents the first part of Chapter 6 of the second edition of the European Guidelines for Quality Assurance in Cervical Cancer Screening. It provides guidance on how to manage women with abnormal cervical cytology. Throughout this article the Bethesda system is used for cervical cytology terminology, as the European guidelines have recommended that all systems should at least be translated into that terminology while cervical intraepithelial neoplasia (CIN) is used for… CONTINUE READING

View on Wiley

onlinelibrary.wiley.com

Save to Library

Create Alert

Cite

Launch Research Feed